Treating the Symptom, Missing the System: Why Single-Fix Consultancy Rarely Holds

Every year, UK firms commission advice against the thing that hurts most and is easiest to name. The pipeline is thin. The board is slow. The team is restless. A specialist is appointed, a programme is run, the named symptom improves — and eighteen months later a variant of it reappears, wearing a different coat.

The pattern is common enough that it deserves a plainer name than bad luck. It is symptom-buying: the habit of purchasing consultancy as though it were a single corrective dose, aimed at the most visible complaint rather than at the machinery producing it.

The complaint is rarely the commission

Consider what actually happens in a typical commissioning conversation. A managing director describes a problem in the language of the boardroom: we are not converting enough of what we win, our decision-making has become sluggish, our best people are unsettled. A consultancy, sensibly enough, responds to what it has been asked. A proposal is written against the complaint. A workstream is scoped to the complaint. Success is measured against the complaint.

Everyone has behaved rationally, and the brief is nonetheless misaligned with the cause. The symptom has been treated as a specification.

Why symptom-buying feels rational

It would be easy to frame this as a failure of judgement. It is better understood as a consequence of how firms actually experience problems. Symptoms are visible, measurable and shared — they give a leadership team something concrete to agree on. Causes are diffuse, contested and often uncomfortable, because they tend to implicate structures, incentives and decisions that senior people own.

There is also a procurement logic at work. A defined symptom produces a defined scope, which produces a defined fee, which is easier to defend to a finance director or a board than a diagnostic phase whose output is a better question. The pressure to buy something specific is real, and it pushes briefs towards the complaint.

Four symptoms and the systems beneath them

A stalled pipeline. The instinct is to buy lead generation. The cause is frequently qualification: the firm pursues work it should decline, prices without authority, or has never agreed what a good client looks like. More leads into a broken filter produces more wasted effort, not more revenue.

A slow board. The instinct is to buy facilitation or governance training. The cause is usually the paper: packs that inform without asking, items that arrive without a decision attached, and decision rights that were never explicitly allocated. Nobody is slow on purpose; the agenda has simply been built to discuss rather than to decide.

A restless team. The instinct is to buy engagement work or a culture programme. The cause is often more mundane — workload distributed unevenly, progression criteria that nobody can articulate, or a manager promoted for technical excellence and left unsupported in a role that requires something else entirely.

Flat margin. The instinct is to buy a cost review. The cause often sits in the mix and the discounting habit: a slow drift towards lower-value work, and a concessions culture in which the person closest to the client has every incentive to close and none to hold price.

In each case the symptom is real. It is also downstream.

The brief test: three substitutions

A brief does not need to be long to be cause-led. It needs three substitutions.

Replace the noun with the mechanism. Not we need a pipeline programme, but we need to understand why qualified opportunities stall between proposal and signature. The first is a purchase; the second is a question an adviser can genuinely work on.

Replace the outcome with the observable. Not we want a faster board, but we want board papers that carry a single decision each and meetings that close items rather than defer them. Observable behaviours can be designed against; aspirations cannot.

Name what must change internally. If the honest answer is that nothing inside the firm will move, the engagement is unlikely to hold — however good the adviser. Writing down the internal change you are prepared to make is the most useful discipline available at the briefing stage, and the least commonly practised.

What a cause-led brief looks like

The difference is usually one paragraph. Before: we are concerned about the pace of decision-making and would like support to improve board effectiveness. After: our board meets monthly, carries twelve papers and closes an average of two items; decisions taken at board level are frequently remade at executive level the following week; we do not have a written allocation of decision rights. We want to understand which of these is driving the pattern, and we are prepared to change the paper format and the delegation schedule.

The second brief costs a little more thought and considerably less money over time. It also gives the adviser something to be wrong about, which is a feature rather than a flaw — a proposition that can be tested is worth more than a workstream that can only be delivered.

The objection: urgency

Buyers will reasonably object that diagnosis takes time and the problem is pressing. Sometimes the objection is justified, and a stabilising intervention is the right call. But an urgent fix and a cause-led brief are not opposites. The difference is whether the engagement includes, at its outset, an explicit commitment to trace the pattern — and whether the final deliverable says something about the system, not only about the symptom.

What urgency should not be permitted to do is convert a hypothesis into a certainty before anyone has examined it.

Buying for the cause is not buying a bigger project

There is a persistent assumption that cause-led commissioning means larger fees and sprawling programmes. In our experience the reverse is often true. A brief that names the mechanism tends to narrow the work rather than widen it, because it excludes the activities that were never going to move the number. Firms that buy by symptom frequently pay for two engagements: the one that addressed the complaint, and the one that later addressed the cause.

The discipline that follows

The practical challenge is small and awkward: before commissioning advice, describe the problem in a sentence that would still be true if the most visible symptom disappeared tomorrow. If no such sentence can be written, the diagnosis has not been done — and no consultant can do it on the buyer's behalf without being paid to ask questions the buyer could have asked for free.

Consultancy is not a silver bullet, and treating it as one flatters both parties. It flatters the buyer, who is spared a harder look at the operating system. It flatters the adviser, who is invited to claim credit for an improvement that may not survive the next quarter. The more honest arrangement is also the more commercial one: buy the cause, name the internal change, and let the symptom take care of itself.